pI: 7.3565 |
Length (AA): 214 |
MW (Da): 22602 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 209 | 4unr (A) | 1 | 209 | 99.00 | 0 | 1 | 2.03854 | -0.98 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_126920)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G59440 | protein ZEU1 (ZEUS1) |
Babesia bovis | BBOV_III006440 | thymidylate kinase, putative |
Brugia malayi | Bm1_23075 | thymidylate kinase |
Candida albicans | CaO19.1137 | Thymidylate kinase |
Candida albicans | CaO19.8730 | Thymidylate kinase |
Caenorhabditis elegans | CELE_R53.2 | Protein R53.2 |
Cryptosporidium hominis | Chro.50490 | thymidylate kinase |
Cryptosporidium parvum | cgd5_3630 | thymidylate kinase |
Chlamydia trachomatis | CT_188 | thymidylate kinase |
Dictyostelium discoideum | DDB_G0290033 | dTMP kinase |
Drosophila melanogaster | Dmel_CG5757 | CG5757 gene product from transcript CG5757-RB |
Escherichia coli | b1098 | thymidylate kinase |
Echinococcus granulosus | EgrG_000756200 | thymidylate kinase |
Entamoeba histolytica | EHI_008040 | Thymidylate kinase, putative |
Echinococcus multilocularis | EmuJ_000756200 | thymidylate kinase |
Giardia lamblia | GL50803_15380 | CDC8 |
Homo sapiens | ENSG00000168393 | deoxythymidylate kinase (thymidylate kinase) |
Leishmania braziliensis | LbrM.10.0060 | thymidylate kinase-like protein |
Leishmania donovani | LdBPK_100040.1 | thymidylate kinase-like protein |
Leishmania infantum | LinJ.10.0040 | thymidylate kinase-like protein |
Leishmania major | LmjF.10.0060 | thymidylate kinase-like protein |
Leishmania mexicana | LmxM.10.0060 | thymidylate kinase-like protein |
Loa Loa (eye worm) | LOAG_01297 | thymidylate kinase |
Mycobacterium leprae | ML0772 | probable thymidylate kinase Tmk (dTMP KINASE) (THYMIDYLIC ACID KINASE) (TMPK) |
Mus musculus | ENSMUSG00000026281 | deoxythymidylate kinase |
Mycobacterium tuberculosis | Rv3247c | Thymidylate kinase Tmk (dTMP kinase) (thymidylic acid kinase) (TMPK) |
Mycobacterium ulcerans | MUL_2583 | thymidylate kinase |
Neospora caninum | NCLIV_053180 | Thymidylate kinase, related |
Oryza sativa | 4344056 | Os07g0639900 |
Onchocerca volvulus | OVOC10889 | Putative thymidylate kinase |
Plasmodium berghei | PBANKA_1464200 | thymidylate kinase, putative |
Plasmodium falciparum | PF3D7_1251300 | thymidylate kinase |
Plasmodium knowlesi | PKNH_1471300 | thymidylate kinase, putative |
Plasmodium vivax | PVX_101455 | thymidylate kinase, putative |
Plasmodium yoelii | PY01336 | Thymidylate kinase |
Saccharomyces cerevisiae | YJR057W | bifunctional thymidylate/uridylate kinase |
Schistosoma japonicum | Sjp_0008250 | ko:K00943 dTMP kinase [EC2.7.4.9], putative |
Schistosoma japonicum | Sjp_0056420 | Thymidylate kinase, putative |
Schistosoma mansoni | Smp_027740 | hypothetical protein |
Schistosoma mansoni | Smp_032810 | thymidylate kinase |
Schistosoma mansoni | Smp_001360 | thymidylate kinase |
Schmidtea mediterranea | mk4.014274.01 | |
Schmidtea mediterranea | mk4.004278.02 | |
Schmidtea mediterranea | mk4.001266.05 | Probable thymidylate kinase |
Trypanosoma brucei gambiense | Tbg972.8.3620 | thymidylate kinase, putative |
Trypanosoma brucei | Tb11.v5.0738 | thymidylate kinase, putative |
Trypanosoma brucei | Tb927.8.3510 | thymidylate kinase, putative |
Trypanosoma congolense | TcIL3000_0_00560 | thymidylate kinase, putative |
Trypanosoma congolense | TcIL3000_8_3770 | thymidylate kinase, putative |
Trypanosoma cruzi | TcCLB.506685.30 | thymidylate kinase, putative |
Trypanosoma cruzi | TcCLB.509663.30 | thymidylate kinase, putative |
Toxoplasma gondii | TGME49_306970 | thymidylate kinase |
Treponema pallidum | TP0354 | thymidylate kinase (tmk) |
Theileria parva | TP02_0319 | thymidylate kinase, putative |
Trichomonas vaginalis | TVAG_134830 | thymidylate kinase, putative |
Trichomonas vaginalis | TVAG_315260 | thymidylate kinase, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0148 | thymidylate kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.3910 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.3910 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.3910 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.3910 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.8.3510 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.3510 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.3510 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.8.3510 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b1098 | Escherichia coli | essential | goodall |
CELE_R53.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_R53.2 | Caenorhabditis elegans | larval arrest | wormbase |
YJR057W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_306970 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Plasmodium falciparum | thymidylate kinase | Compounds | References |
Homo sapiens | deoxythymidylate kinase (thymidylate kinase) | Compounds | References |